OROS® Hydromorphone Prolonged Release: A Review of its Use in the Management of Chronic, Moderate to Severe Pain

Author： Carter Natalie J.   Keating Gillian M.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.24, Iss.4, 2010-04, pp. : 337-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic conditions no longer a pain with OROS hydromorphone

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 504, 2006-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Tapentadol Immediate Release: A Review of its Use in the Treatment of Moderate to Severe Acute Pain

By Frampton James E.  

Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. : 1719-1743

Adis International

Access to resources Recommend Favorite

Tramadol/Paracetamol Fixed-Dose Combination: A Review of its Use in the Management of Moderate to Severe Pain

By Dhillon Sohita  

Clinical Drug Investigation, Vol. 30, Iss. 10, 2010-10 ,pp. : 711-738

Adis International

Access to resources Recommend Favorite

Ustekinumab: A Review of its Use in the Management of Moderate To Severe Plaque Psoriasis

By Croxtall Jamie D.  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1733-1753

Adis International

Access to resources Recommend Favorite

OROS hydromorphone of value for osteoarthritis pain

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 543, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite